US Physicalrapy Ownership

USPH Stock  USD 88.55  0.23  0.26%   
The majority of US Physicalrapy outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to take positions in US Physicalrapy to benefit from reduced commissions. Therefore, outside corporations are subject to a different set of regulations than regular investors in US Physicalrapy. Please pay attention to any change in the institutional holdings of US Physicalrapy as this could imply that something significant has changed or is about to change at the company. On November 7, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of US Physicalrapy's common stock.
Some institutional investors establish a significant position in stocks such as US Physicalrapy in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of US Physicalrapy, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

USPH Stock Ownership Analysis

About 98.0% of the company outstanding shares are owned by institutional investors. The book value of US Physicalrapy was at this time reported as 32.02. The company last dividend was issued on the 15th of November 2024. US Physicalrapy had 3:2 split on the 29th of June 2001. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company was founded in 1990 and is based in Houston, Texas. US Physical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 3158 people. For more information please call Christopher Reading at 713 297 7000 or visit https://www.usph.com.

US Physicalrapy Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific US Physicalrapy insiders, such as employees or executives, is commonly permitted as long as it does not rely on US Physicalrapy's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases US Physicalrapy insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Bernard Harris over a month ago
Acquisition by Bernard Harris of 1600 shares of US Physicalrapy subject to Rule 16b-3
 
Richard Binstein over a month ago
Disposition of 1128 shares by Richard Binstein of US Physicalrapy at 98.52 subject to Rule 16b-3
 
Bernard Harris over two months ago
Disposition of 2000 shares by Bernard Harris of US Physicalrapy at 92.95 subject to Rule 16b-3
 
Kathleen Gilmartin over three months ago
Acquisition by Kathleen Gilmartin of 600 shares of US Physicalrapy at 92.26 subject to Rule 16b-3
 
Christopher Reading over three months ago
Disposition of 2900 shares by Christopher Reading of US Physicalrapy at 100.26 subject to Rule 16b-3
 
Carey Hendrickson over three months ago
Disposition of 1788 shares by Carey Hendrickson of US Physicalrapy at 107.28 subject to Rule 16b-3
 
Richard Binstein over three months ago
Disposition of 1808 shares by Richard Binstein of US Physicalrapy at 90.43 subject to Rule 16b-3
 
Eric Williams over six months ago
Disposition of 500 shares by Eric Williams of US Physicalrapy at 101.6 subject to Rule 16b-3
 
Christopher Reading over six months ago
Disposition of 1100 shares by Christopher Reading of US Physicalrapy at 102.13 subject to Rule 16b-3
 
Ham Nancy over six months ago
Acquisition by Ham Nancy of 1424 shares of US Physicalrapy subject to Rule 16b-3
 
Edward Kuntz over six months ago
Disposition of 2500 shares by Edward Kuntz of US Physicalrapy at 107.57 subject to Rule 16b-3
 
Graham Reeve over six months ago
Disposition of 1724 shares by Graham Reeve of US Physicalrapy at 105.46 subject to Rule 16b-3

US Physicalrapy's latest congressional trading

Congressional trading in companies like US Physicalrapy, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in US Physicalrapy by those in governmental positions are based on the same information available to the general public.
2024-11-07Representative Josh GottheimerAcquired Under $15KVerify
2024-11-06Representative Josh GottheimerAcquired Under $15KVerify
2024-10-04Representative Josh GottheimerAcquired Under $15KVerify
2024-10-03Representative Josh GottheimerAcquired Under $15KVerify

US Physicalrapy Outstanding Bonds

US Physicalrapy issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. US Physicalrapy uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most USPH bonds can be classified according to their maturity, which is the date when US Physicalrapy has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.